Today, MetLife Inc. (MET) Position Decreased by Sei Investments Co.

Today, MetLife Inc. (MET) Position Decreased by Sei Investments Co.

Sei Investments Co. reduced its position in shares of MetLife Inc. (NYSE:MET) by 7.5% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 733,454 shares of the company’s stock after selling 59,421 shares during the period. Sei Investments Co. owned approximately 0.07% of MetLife worth $32,588,000 at the end of the most recent quarter.

Several other institutional investors have also made changes to their positions in the stock. Livingston Group Asset Management CO operating as Southport Capital Management acquired a new position in shares of MetLife during the second quarter worth about $110,000. ClariVest Asset Management LLC raised its position in shares of MetLife by 0.3% in the second quarter. ClariVest Asset Management LLC now owns 2,806 shares of the company’s stock worth $112,000 after buying an additional 8 shares during the last quarter. Manchester Capital Management LLC raised its position in shares of MetLife by 0.3% in the second quarter. Manchester Capital Management LLC now owns 2,891 shares of the company’s stock worth $115,000 after buying an additional 9 shares during the last quarter. Carroll Financial Associates Inc. raised its position in shares of MetLife by 51.5% in the third quarter. Carroll Financial Associates Inc. now owns 2,625 shares of the company’s stock worth $116,000 after buying an additional 892 shares during the last quarter. Finally, First New York Securities LLC NY acquired a new position in shares of MetLife during the second quarter worth about $119,000. 73.45% of the stock is currently owned by institutional investors.

Shares of MetLife Inc. (NYSE:MET) traded down 0.20% during mid-day trading on Friday, hitting $55.24. The stock had a trading volume of 1,122,336 shares. The stock has a market cap of $60.72 billion, a price-to-earnings ratio of 16.97 and a beta of 1.66. MetLife Inc. has a 12-month low of $35.00 and a 12-month high of $55.49. The firm’s 50-day moving average price is $49.16 and its 200 day moving average price is $44.29.

MetLife (NYSE:MET) last posted its earnings results on Wednesday, November 2nd. The company reported $1.28 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.24 by $0.04. The business earned $17.70 billion during the quarter, compared to the consensus estimate of $17.03 billion. MetLife had a return on equity of 6.99% and a net margin of 5.58%. MetLife’s revenue was down 99.9% on a year-over-year basis. During the same quarter last year, the company earned $0.62 EPS. Equities analysts forecast that MetLife Inc. will post $4.63 EPS for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 13th. Investors of record on Monday, November 7th will be given a dividend of $0.40 per share. The ex-dividend date is Thursday, November 3rd. This represents a $1.60 annualized dividend and a dividend yield of 2.89%. MetLife’s dividend payout ratio (DPR) is presently 49.23%.

MET has been the subject of a number of research analyst reports. Wells Fargo & Co. reiterated an “outperform” rating on shares of MetLife in a report on Friday, September 23rd. TheStreet downgraded MetLife from a “buy” rating to a “hold” rating in a report on Wednesday, August 24th. Argus reiterated a “buy” rating and issued a $54.00 price target on shares of MetLife in a report on Wednesday, September 7th. FBR & Co boosted their price target on MetLife from $51.00 to $54.00 and gave the company an “outperform” rating in a report on Monday, August 29th. Finally, Zacks Investment Research downgraded MetLife from a “hold” rating to a “sell” rating in a report on Wednesday, October 26th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating, twelve have given a buy rating and two have assigned a strong buy rating to the company’s stock. MetLife currently has a consensus rating of “Buy” and an average price target of $51.35.

In related news, EVP Frans Hijkoop sold 56,250 shares of the firm’s stock in a transaction on Wednesday, November 9th. The stock was sold at an average price of $51.48, for a total transaction of $2,895,750.00. Following the completion of the sale, the executive vice president now directly owns 111,813 shares of the company’s stock, valued at approximately $5,756,133.24. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Maria R. Morris sold 8,800 shares of the firm’s stock in a transaction on Tuesday, October 4th. The shares were sold at an average price of $45.00, for a total value of $396,000.00. Following the sale, the executive vice president now directly owns 116,409 shares of the company’s stock, valued at $5,238,405. The disclosure for this sale can be found here. Corporate insiders own 0.27% of the company’s stock.

About MetLife

Related posts

Leave a Comment